Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Price:
73.65 CNY
-0.99%
Market Closed
Updated:
May 25, 2024
P/OCF
Price to OCF
Price to OCF
38.6
Current
43.2
Median
15.6
Industry
Lower
than median
Higher
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=38.6
Market Cap
/
57.9B
Operating Cash Flow
1.5B
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
57.9B CNY | 38.6 | |
| CH |
|
Alcon AG
SIX:ALC
|
40.6B CHF | 27 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.5T JPY | 31.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
189.8B DKK | 83.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
19.2B USD | 24.5 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 33.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 17.8 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.7B USD | 13.5 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.3B CHF | 39.6 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 16.7 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.3B USD | 66 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
